| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | developmental process involved in reproduction | 7.37e-04 | 1235 | 8 | 4 | GO:0003006 | |
| GeneOntologyCellularComponent | clathrin-coated vesicle | 3.43e-03 | 237 | 8 | 2 | GO:0030136 | |
| Pathway | REACTOME_CELLULAR_RESPONSES_TO_STIMULI | 1.91e-02 | 828 | 4 | 2 | M27827 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | 1.70e-02 | 1192 | 8 | 2 | chr19q13 | |
| Coexpression | DIRMEIER_LMP1_RESPONSE_EARLY | 1.53e-04 | 62 | 8 | 2 | M13941 | |
| Coexpression | GAUTAM_EYE_IRIS_CILIARY_BODY_CRYAA_HIGH_CILIARY_BODY_CELLS | 2.67e-04 | 82 | 8 | 2 | M43626 | |
| Coexpression | PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN | 7.44e-04 | 137 | 8 | 2 | M4781 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_ENDOTHELIAL_CELL_OF_CORONARY_ARTERY_AGEING | 7.77e-04 | 140 | 8 | 2 | MM3705 | |
| Coexpression | TABULA_MURIS_SENIS_PANCREAS_PANCREATIC_ALPHA_CELL_AGEING | 7.99e-04 | 142 | 8 | 2 | MM3815 | |
| Coexpression | GSE36891_UNSTIM_VS_POLYIC_TLR3_STIM_PERITONEAL_MACROPHAGE_UP | 8.79e-04 | 149 | 8 | 2 | M8786 | |
| Coexpression | GSE37605_TREG_VS_TCONV_NOD_FOXP3_FUSION_GFP_UP | 8.91e-04 | 150 | 8 | 2 | M8796 | |
| Coexpression | NAGASHIMA_NRG1_SIGNALING_UP | 1.17e-03 | 172 | 8 | 2 | M11585 | |
| Coexpression | BLANCO_MELO_COVID19_SARS_COV_2_LOW_MOI_INFECTION_A594_ACE2_EXPRESSING_CELLS_UP | 1.20e-03 | 174 | 8 | 2 | M34014 | |
| Coexpression | GSE27859_MACROPHAGE_VS_CD11C_INT_F480_HI_MACROPHAGE_UP | 1.21e-03 | 175 | 8 | 2 | M8593 | |
| Coexpression | JIANG_MELANOMA_TRM1_CD8 | 1.24e-03 | 177 | 8 | 2 | M48965 | |
| Coexpression | GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_C57BL6_UP | 1.35e-03 | 185 | 8 | 2 | M8792 | |
| Coexpression | GSE2706_R848_VS_R848_AND_LPS_2H_STIM_DC_UP | 1.38e-03 | 187 | 8 | 2 | M4714 | |
| Coexpression | JIANG_MELANOMA_TRM5_CD8 | 1.41e-03 | 189 | 8 | 2 | M48969 | |
| Coexpression | GSE2706_UNSTIM_VS_2H_R848_DC_DN | 1.48e-03 | 194 | 8 | 2 | M4692 | |
| Coexpression | GSE9988_LOW_LPS_VS_VEHICLE_TREATED_MONOCYTE_UP | 1.51e-03 | 196 | 8 | 2 | M5873 | |
| Coexpression | GSE9988_LPS_VS_VEHICLE_TREATED_MONOCYTE_UP | 1.53e-03 | 197 | 8 | 2 | M5860 | |
| Coexpression | GSE20152_SPHK1_KO_VS_WT_HTNFA_OVERXPRESS_ANKLE_UP | 1.54e-03 | 198 | 8 | 2 | M7684 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_DC_UP | 1.56e-03 | 199 | 8 | 2 | M5399 | |
| Coexpression | GSE23925_LIGHT_ZONE_VS_NAIVE_BCELL_UP | 1.56e-03 | 199 | 8 | 2 | M7885 | |
| Coexpression | GSE22229_UNTREATED_VS_IMMUNOSUPP_THERAPY_RENAL_TRANSPLANT_PATIENT_PBMC_UP | 1.57e-03 | 200 | 8 | 2 | M7478 | |
| Coexpression | HALLMARK_TNFA_SIGNALING_VIA_NFKB | 1.57e-03 | 200 | 8 | 2 | M5890 | |
| Coexpression | GSE5589_WT_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_UP | 1.57e-03 | 200 | 8 | 2 | M6649 | |
| Coexpression | GSE32986_CURDLAN_HIGHDOSE_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN | 1.57e-03 | 200 | 8 | 2 | M8631 | |
| Coexpression | GSE2585_CTEC_VS_THYMIC_MACROPHAGE_UP | 1.57e-03 | 200 | 8 | 2 | M6268 | |
| Coexpression | HALLMARK_MTORC1_SIGNALING | 1.57e-03 | 200 | 8 | 2 | M5924 | |
| Coexpression | GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_VISCERAL_ADIPOSE_TISSUE_DN | 1.57e-03 | 200 | 8 | 2 | M8956 | |
| Coexpression | GSE14769_UNSTIM_VS_20MIN_LPS_BMDM_DN | 1.57e-03 | 200 | 8 | 2 | M3491 | |
| Coexpression | GSE14769_UNSTIM_VS_40MIN_LPS_BMDM_DN | 1.57e-03 | 200 | 8 | 2 | M3497 | |
| Coexpression | GSE22140_GERMFREE_VS_SPF_MOUSE_CD4_TCELL_DN | 1.57e-03 | 200 | 8 | 2 | M7644 | |
| Coexpression | GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4MID_SORTED_BCELL_UP | 1.57e-03 | 200 | 8 | 2 | M9833 | |
| Coexpression | GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4HIGH_SORTED_BCELL_DN | 1.57e-03 | 200 | 8 | 2 | M9830 | |
| Coexpression | GSE24210_IL35_TREATED_VS_RESTING_TREG_UP | 1.57e-03 | 200 | 8 | 2 | M7848 | |
| Coexpression | GSE13306_RA_VS_UNTREATED_TREG_UP | 1.57e-03 | 200 | 8 | 2 | M3232 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_CENT_MEMORY_CD4_TCELL_UP | 1.57e-03 | 200 | 8 | 2 | M5418 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_EFF_MEMORY_CD4_TCELL_UP | 1.57e-03 | 200 | 8 | 2 | M5416 | |
| Coexpression | DESCARTES_FETAL_CEREBRUM_ASTROCYTES | 1.67e-03 | 206 | 8 | 2 | M40171 | |
| Coexpression | PHONG_TNF_RESPONSE_VIA_P38_COMPLETE | 1.97e-03 | 224 | 8 | 2 | M2500 | |
| Coexpression | ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF | 2.11e-03 | 232 | 8 | 2 | M2613 | |
| Coexpression | BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING | 2.20e-03 | 237 | 8 | 2 | M7068 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.59e-06 | 182 | 8 | 3 | 587636c0f127231de21acd8aa632b74ff22ca8c2 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.59e-06 | 182 | 8 | 3 | adfadd7893e74b3002f13f00875e3667d3493e0c | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Cyp26b1_(Deep_layer_pyramidal_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.94e-05 | 54 | 8 | 2 | 4daa84df51cc99113a9f8e86b1ae09bd76a9c991 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Cyp26b1_(Deep_layer_pyramidal_cells)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.94e-05 | 54 | 8 | 2 | 2e177a9fd0f7c033dbcfa8b41b76658d8268644c | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P3-Tnr|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.08e-04 | 89 | 8 | 2 | e7abf4af18d63c9384d25365a827e85a9adee964 | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cspg5_(Cspg5)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.08e-04 | 89 | 8 | 2 | 436e1229ee28517c11dfe0a5d1cdad3477419e00 | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P3|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.08e-04 | 89 | 8 | 2 | 9e7041ab9409028007fefe53db6d1048eafae93b | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cspg5_(Cspg5)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.08e-04 | 89 | 8 | 2 | 4e5f4c0404968422703c248488e6b2ee8737dc00 | |
| ToppCell | Severe-B_naive-13|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.83e-04 | 116 | 8 | 2 | f81a7c3e9cbf39124232d98e2a3a3e308137f391 | |
| ToppCell | Severe-B_naive-13|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.95e-04 | 120 | 8 | 2 | d08edc09de8497714af55a6ca08a447cd71095e7 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-AT1_Progenitor|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.93e-04 | 147 | 8 | 2 | a82a971a934faff6806823ca62a398b429ecd9c8 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.09e-04 | 151 | 8 | 2 | f41c6558a5874b6464c157027fdf202257c60e5b | |
| ToppCell | control-Myeloid-Neutrophils_4|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.17e-04 | 153 | 8 | 2 | 87dc61f7dd76b42c4d1e14fd33958b6a02116bc8 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c08-GZMK-FOS_h|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.22e-04 | 154 | 8 | 2 | 89c9c9918af32f3952790b41f1471b2c80ffce2f | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 3.26e-04 | 155 | 8 | 2 | c4dc0fa1d0e657753a56939eb4829fb60382c17f | |
| ToppCell | normal_Lymph_Node-T/NK_cells-CD8+/CD4+_Mixed_Th|normal_Lymph_Node / Location, Cell class and cell subclass | 3.56e-04 | 162 | 8 | 2 | 12bd0b99aee13da60d0684a5e2a705824db1899c | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.60e-04 | 163 | 8 | 2 | 6bed27d2f67a430a847da5eb47878d14b4949c45 | |
| ToppCell | PND01-03-samps-Epithelial-Alveolar_epithelial-AT1|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 3.69e-04 | 165 | 8 | 2 | b9b6b7b8cd65ba6948a5dd8b715cc7092e0be637 | |
| ToppCell | normal_Lymph_Node-T/NK_cells-CD8+/CD4+_Mixed_Th|T/NK_cells / Location, Cell class and cell subclass | 3.73e-04 | 166 | 8 | 2 | d638d356592325cded4a6cb549041cf2f8d3e62c | |
| ToppCell | lung-Ciliated_Epithelia|lung / shred on tissue and cell subclass | 3.78e-04 | 167 | 8 | 2 | 26cf1cfa58ee74794449a87eb19cd896e1ec8892 | |
| ToppCell | COVID-19-Myeloid-MoAM5,_CCL3L1|Myeloid / Condition, Lineage and Cell class | 3.82e-04 | 168 | 8 | 2 | ea465152ea31391b63c02425beafa9a4f51f6703 | |
| ToppCell | BAL-Severe-cDC_5|Severe / Compartment, Disease Groups and Clusters | 3.82e-04 | 168 | 8 | 2 | 857a80c217a5513553460798a625612031bc7bb7 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.87e-04 | 169 | 8 | 2 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.87e-04 | 169 | 8 | 2 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | Ciliated_cells-A-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 3.92e-04 | 170 | 8 | 2 | 3d3a03979014df3a05c49be18010c6b94d786707 | |
| ToppCell | Severe-B_activate-7|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.96e-04 | 171 | 8 | 2 | 61205a4986c2d0a89aea96ed8dec9e952eeb6ff1 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Deuterosomal|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.96e-04 | 171 | 8 | 2 | 52aec5f6677fe2f7a36fb5b18117a4cffaeff58f | |
| ToppCell | Immune_cells-B_cell|Immune_cells / Lineage and Cell class | 4.01e-04 | 172 | 8 | 2 | b646894b691a99bf2742bd9da8e578dff0e87f1f | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.05e-04 | 173 | 8 | 2 | 5b76d9cc56bbb29017e64a2d0a3c76c0be003d96 | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil-Neutrophil-Neu_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.05e-04 | 173 | 8 | 2 | bf685025961e79b379f2c35464b6c8ce3e31ace0 | |
| ToppCell | droplet-Lung-21m-Epithelial-airway_epithelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.05e-04 | 173 | 8 | 2 | a809be2630d2b91b53b82b5e2bb99e05524597c1 | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.05e-04 | 173 | 8 | 2 | c37dba3804df7c3151e18e6ae4e0b6e7a92bae97 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.05e-04 | 173 | 8 | 2 | d56e337eae727a29cd53cfd628e1b3c0a98e1f51 | |
| ToppCell | COVID-19-Myeloid-MoAM5,_CCL3L1|COVID-19 / Condition, Lineage and Cell class | 4.05e-04 | 173 | 8 | 2 | 502f888b7684ed39f5c577eedcacf673ae81d39e | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil-Neutrophil-Neu_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.05e-04 | 173 | 8 | 2 | 1edef5aeab626cbf2c09468e77b02cfa2d21ba03 | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.05e-04 | 173 | 8 | 2 | a6e73a40b0d5356564a594053e772f9d061a5919 | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.05e-04 | 173 | 8 | 2 | a8b5370f4c893a20c58e97659f3ac168699693f8 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.20e-04 | 176 | 8 | 2 | dee780cfa85234a7cd7bf440b66b84cec959893e | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.5.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.20e-04 | 176 | 8 | 2 | b99e20e4dd8b3322c9d7a08d518ed4f8f356b3de | |
| ToppCell | facs-Trachea-3m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell-ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.24e-04 | 177 | 8 | 2 | 3cfde67b93f3986312f5e74e42504214d966e7dc | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Classical_Monocyte-Mono_c1-CD14-CCL3|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.24e-04 | 177 | 8 | 2 | fd739ae4a574b72dc26a2a9ff4ef988454298ead | |
| ToppCell | Ciliated_cells-B-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 4.24e-04 | 177 | 8 | 2 | c38138fb5ad9766c2d240811210c854338cd612e | |
| ToppCell | facs-Trachea-3m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.24e-04 | 177 | 8 | 2 | 12a52a12a87a31e501ced611f46a90d172ca7e35 | |
| ToppCell | Severe_COVID-19-Myeloid-Neutrophil|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 4.24e-04 | 177 | 8 | 2 | a6fae376f1beb1df423484d9b1bd1d954ca117af | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Epithelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.29e-04 | 178 | 8 | 2 | 58857bb8c13e0e1c6d9f5c1258f00fff62063d68 | |
| ToppCell | normal_Lung-Myeloid_cells-CD163+CD14+_DCs|normal_Lung / Location, Cell class and cell subclass | 4.29e-04 | 178 | 8 | 2 | b6dacaad09bf4384d0d4c926fbf769e74a8ec9a9 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Epithelial-epithelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.29e-04 | 178 | 8 | 2 | b0baf5667e3301898b3e45e974b8a8530af6a338 | |
| ToppCell | facs-Heart-RA-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.29e-04 | 178 | 8 | 2 | b505e2550860e777535ee95f29c936242fd607f1 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Epithelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.29e-04 | 178 | 8 | 2 | 8b7df6ab8709d9ab9dff97677cc4561aec2745bc | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Monocytic-Classical_Monocyte-Mono_c2-CD14-HLA-DPB1|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.34e-04 | 179 | 8 | 2 | 8f7d2730188f67e8ca290c60ba171fc13e0cf69e | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.34e-04 | 179 | 8 | 2 | 2fca4117c58824562ec80c7713fe15689a28efb3 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.34e-04 | 179 | 8 | 2 | 9dd8d19050223cdebec2579014892b759e5e9de8 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.34e-04 | 179 | 8 | 2 | 898425fa81526a2e00fca7a25085229ff1f31069 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.39e-04 | 180 | 8 | 2 | dcec59d66995f701d816eaeea3ed1439a2f71b73 | |
| ToppCell | facs-Trachea-nan-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.39e-04 | 180 | 8 | 2 | cf6e9f757afeb342c5023f6e6152a1b4d0d164b4 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.39e-04 | 180 | 8 | 2 | f3d8329b7e754c1ed89b0f39b8cd9e2ae22f6725 | |
| ToppCell | Control-Myeloid-MoAM2|Control / Disease group,lineage and cell class （2021.01.30） | 4.39e-04 | 180 | 8 | 2 | 38892483a6a5388765aec87f0119c0b9bb5c7cbd | |
| ToppCell | (1)_B_cells-(1)_B_CD27pos|(1)_B_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 4.44e-04 | 181 | 8 | 2 | d2476956ca13f9234d7e77c3ee432dd54eebeac4 | |
| ToppCell | Mesenchymal_cells-Stromal_fibro.|Mesenchymal_cells / Lineage and Cell class | 4.44e-04 | 181 | 8 | 2 | f8d914fdc06aaa75a4dc9158daf574ca28fa5432 | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Endometrioid-4|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 4.44e-04 | 181 | 8 | 2 | 51d91b923920463245e95d65c6a5197e21d34d73 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.48e-04 | 182 | 8 | 2 | f5f42e23832d0210560009ce6fd8eee89751e252 | |
| ToppCell | facs-Heart-LV-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.48e-04 | 182 | 8 | 2 | 6dff753d65ba45db81f3cc0c9f59e1779d490955 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Deuterosomal|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.48e-04 | 182 | 8 | 2 | 000eca5baa6eb2335a1e6d76a13fff5382b0e150 | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_neutrophil-granulo-eo/baso/mast-basophil|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.53e-04 | 183 | 8 | 2 | f9a3af96c0fb7d5c4d7df6db8b2c42e322418c08 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-04 | 184 | 8 | 2 | 22010cfe0428ebfa40952cc1a1a12ad3d25b35c9 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.58e-04 | 184 | 8 | 2 | 5daff849625f2f41d56615569c0ed59cd733b34c | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-04 | 184 | 8 | 2 | 264e14aa1859cfc0ed5fb40e97ea189aed9ef4a5 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-04 | 184 | 8 | 2 | d7eccbd21c480d907fdc8eff2bf5ae22ae452221 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-B_cells-Naive_B|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.58e-04 | 184 | 8 | 2 | a068ae741889d59937690c11e0bf405481402c25 | |
| ToppCell | Severe-B_memory-0|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.63e-04 | 185 | 8 | 2 | 0a2a3acc8747f4ad8c4d37e76378cca6852b9952 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.63e-04 | 185 | 8 | 2 | 3e39a3cb534dfe2301930f3e2f7e8cefb522c158 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.63e-04 | 185 | 8 | 2 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | LPS_only|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.63e-04 | 185 | 8 | 2 | a72ccb147ca505880e2da8f6a70b9d570464a691 | |
| ToppCell | Monocytes-IL1B+_Monocytes|Monocytes / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 4.63e-04 | 185 | 8 | 2 | cbe54b605f417a01b3b5d2ec75565ee3b5a9ba06 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.68e-04 | 186 | 8 | 2 | bd1185592aedebccd1007dbf2dd2f549fcdf9f42 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.68e-04 | 186 | 8 | 2 | 55b239834b96b1f7787ec77a7d19796d617bbbf0 | |
| ToppCell | Ciliated_cells-B-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 4.73e-04 | 187 | 8 | 2 | 2b4262c2e7c7830a976be168cee6eeb738d4feda | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.73e-04 | 187 | 8 | 2 | 9e10ed56090d82589bc457788282f664b70ace4b | |
| ToppCell | E15.5-Epithelial-alveolar_epithelial_cell-type_II_pneumocyte|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.73e-04 | 187 | 8 | 2 | 1288fcd0124c70711521f3ac83554e9acdd37cb2 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.73e-04 | 187 | 8 | 2 | 98026c1aaf8de280470ad75536121357934fc78d | |
| ToppCell | Ciliated_cells-B-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 4.73e-04 | 187 | 8 | 2 | 6fa38dbccca36bc7a4fef46de74c6688f599f421 | |
| ToppCell | Ciliated_cells-B-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 4.73e-04 | 187 | 8 | 2 | bc1f33f332ac939c2425f510173430ca2ba0c3ee | |
| ToppCell | droplet-Lung-18m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.78e-04 | 188 | 8 | 2 | 0eca3dc93724e23b71e687fc24fa9f1e89bdef6a | |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | 4.78e-04 | 188 | 8 | 2 | 34b11f72ca73153d02edcd09b38983ad1a504659 | |
| ToppCell | droplet-Lung-18m-Epithelial-airway_epithelial-lung_ciliated_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.78e-04 | 188 | 8 | 2 | 9ce3e1fffce87ad19812ecbf9b7f9935a975d676 | |
| ToppCell | control-Myeloid-Neutrophils_4|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.78e-04 | 188 | 8 | 2 | 22d76c222fb0e3da08e10191af0090f14e03f2ad | |
| ToppCell | Mild/Remission-B_intermediate-0|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.78e-04 | 188 | 8 | 2 | 614032d18f8060bb12d1af7a1cf1cf4d8b2b505b | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.78e-04 | 188 | 8 | 2 | 5e13725136114e42d3b59647cf25e0f3c53abb54 | |
| ToppCell | droplet-Lung-1m-Epithelial-airway_epithelial-lung_ciliated_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.78e-04 | 188 | 8 | 2 | a7b7ba56603a8a50869b41902aed6a9ab1c5c021 | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 4.78e-04 | 188 | 8 | 2 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | droplet-Lung-1m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.78e-04 | 188 | 8 | 2 | bc0b9ba8ae88e8a89e98b446584ed39606e4229e | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-Trm_Th1/Th17|lymph-node_spleen / Manually curated celltypes from each tissue | 4.78e-04 | 188 | 8 | 2 | a20521198c6db17589535fb439533329582c9dd2 | |
| ToppCell | droplet-Lung-1m-Epithelial-airway_epithelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.78e-04 | 188 | 8 | 2 | 50994e304c719f2f3c3232e48141e2dd15c96612 | |
| ToppCell | B_cells-Naive_B_cells_|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 4.78e-04 | 188 | 8 | 2 | d1bc1316bbb8cfc39acc70f8680b14d19f536997 | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_Cytotoxic_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.78e-04 | 188 | 8 | 2 | c80956649b10b7dd7540394a00fc2a0619b27e80 | |
| ToppCell | COVID-19-lung-Ciliated|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.83e-04 | 189 | 8 | 2 | a2da5debd10f27b1280b40141ef0bfef007cc72c | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 4.83e-04 | 189 | 8 | 2 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | tumor_Lung-MAST_cells-MAST|tumor_Lung / Location, Cell class and cell subclass | 4.83e-04 | 189 | 8 | 2 | cd977962e01756b663728dae32ab9aba15bf7e22 | |
| ToppCell | droplet-Lung-18m-Epithelial-airway_epithelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.83e-04 | 189 | 8 | 2 | fe958fdf9963c2dfe270f67f0da36b3264d0017c | |
| ToppCell | facs-Limb_Muscle|facs / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.83e-04 | 189 | 8 | 2 | 21ec43859d21ffc565acbe36489da1d2d0f9877d | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.10e-04 | 50 | 5 | 2 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_STRESS | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.10e-04 | 50 | 5 | 2 | GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_STRESS | |
| Drug | Dicyclomine hydrochloride [67-92-5]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 3.11e-05 | 190 | 8 | 3 | 1483_UP | |
| Drug | Ethopropazine hydrochloride [1094-08-2]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 3.16e-05 | 191 | 8 | 3 | 5296_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A | 3.25e-05 | 193 | 8 | 3 | 2949_DN | |
| Drug | Metergoline [17692-51-2]; Up 200; 10uM; HL60; HG-U133A | 3.31e-05 | 194 | 8 | 3 | 1606_UP | |
| Drug | Moxalactam disodium salt [64953-12-4]; Down 200; 7uM; PC3; HT_HG-U133A | 3.31e-05 | 194 | 8 | 3 | 4648_DN | |
| Drug | Isopropamide iodide [71-81-8]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 3.36e-05 | 195 | 8 | 3 | 3461_DN | |
| Drug | Trimethoprim [738-70-5]; Down 200; 13.8uM; PC3; HT_HG-U133A | 3.41e-05 | 196 | 8 | 3 | 7377_DN | |
| Drug | Hesperetin [520-33-2]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 3.41e-05 | 196 | 8 | 3 | 1531_DN | |
| Drug | Serotonin hydrochloride [153-98-0]; Up 200; 18.8uM; PC3; HT_HG-U133A | 3.41e-05 | 196 | 8 | 3 | 4673_UP | |
| Drug | F0447-0125; Up 200; 10uM; PC3; HT_HG-U133A | 3.41e-05 | 196 | 8 | 3 | 6401_UP | |
| Drug | Clidinium bromide [3485-62-9]; Down 200; 9.2uM; HL60; HT_HG-U133A | 3.46e-05 | 197 | 8 | 3 | 2734_DN | |
| Drug | Gallamine triethiodide [65-29-2]; Up 200; 4.4uM; PC3; HT_HG-U133A | 3.46e-05 | 197 | 8 | 3 | 2059_UP | |
| Drug | Propantheline bromide [50-34-0]; Down 200; 9uM; HL60; HT_HG-U133A | 3.51e-05 | 198 | 8 | 3 | 3013_DN | |
| Drug | Erythromycin [114-07-8]; Down 200; 5.4uM; MCF7; HT_HG-U133A | 3.51e-05 | 198 | 8 | 3 | 1510_DN | |
| Drug | Xylometazoline hydrochloride [1218-35-5]; Down 200; 14.2uM; PC3; HT_HG-U133A | 3.51e-05 | 198 | 8 | 3 | 2107_DN | |
| Drug | Bisoprolol fumarate; Down 200; 9uM; MCF7; HT_HG-U133A | 3.57e-05 | 199 | 8 | 3 | 2642_DN | |
| Drug | Moxisylyte hydrochoride [964-52-3]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 3.62e-05 | 200 | 8 | 3 | 1682_DN | |
| Drug | Cefepime hydrochloride [123171-59-5]; Down 200; 7.4uM; PC3; HT_HG-U133A | 3.62e-05 | 200 | 8 | 3 | 5761_DN | |
| Drug | hydroxytamoxifen | 7.18e-04 | 117 | 8 | 2 | ctd:C475919 | |
| Drug | mono-(2-ethylhexyl)phthalate | 1.21e-03 | 658 | 8 | 3 | ctd:C016599 | |
| Drug | Astemizole [68844-77-9]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 1.21e-03 | 152 | 8 | 2 | 6807_UP | |
| Drug | Azacyclonol [115-46-8]; Up 200; 15uM; MCF7; HT_HG-U133A | 1.24e-03 | 154 | 8 | 2 | 1520_UP | |
| Drug | thioridazine hydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 1.26e-03 | 155 | 8 | 2 | 1068_UP | |
| Drug | Anisomycin [22862-76-6]; Up 200; 15uM; HL60; HT_HG-U133A | 1.29e-03 | 157 | 8 | 2 | 1304_UP | |
| Drug | Azaguanine-8 [134-58-7]; Up 200; 26.2uM; PC3; HT_HG-U133A | 1.30e-03 | 158 | 8 | 2 | 1791_UP | |
| Drug | Helveticoside [630-64-8]; Up 200; 7.4uM; HL60; HT_HG-U133A | 1.32e-03 | 159 | 8 | 2 | 2192_UP | |
| Drug | Azaguanine-8 [134-58-7]; Up 200; 26.2uM; HL60; HT_HG-U133A | 1.32e-03 | 159 | 8 | 2 | 1833_UP | |
| Drug | Anisomycin [22862-76-6]; Up 200; 15uM; MCF7; HT_HG-U133A | 1.34e-03 | 160 | 8 | 2 | 5364_UP | |
| Drug | Terfenadine [50679-08-8]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 1.35e-03 | 161 | 8 | 2 | 2227_UP | |
| Drug | Thioridazine hydrochloride [130-61-0]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 1.37e-03 | 162 | 8 | 2 | 1486_UP | |
| Drug | Anisomycin [22862-76-6]; Up 200; 15uM; MCF7; HT_HG-U133A | 1.37e-03 | 162 | 8 | 2 | 2658_UP | |
| Drug | Digitoxigenin [143-62-4]; Up 200; 10.6uM; HL60; HT_HG-U133A | 1.37e-03 | 162 | 8 | 2 | 1339_UP | |
| Drug | 5224221; Up 200; 12uM; MCF7; HT_HG-U133A_EA | 1.44e-03 | 166 | 8 | 2 | 956_UP | |
| Drug | Cephaeline dihydrochloride heptahydrate [6487-30-5]; Up 200; 6uM; MCF7; HT_HG-U133A | 1.44e-03 | 166 | 8 | 2 | 3290_UP | |
| Drug | Perhexiline maleate [6724-53-4]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 1.49e-03 | 169 | 8 | 2 | 7441_UP | |
| Drug | Parthenolide [20554-84-1]; Up 200; 16.2uM; HL60; HG-U133A | 1.49e-03 | 169 | 8 | 2 | 1736_UP | |
| Drug | Digoxin [20830-75-5]; Up 200; 5.2uM; PC3; HT_HG-U133A | 1.49e-03 | 169 | 8 | 2 | 6724_UP | |
| Drug | Perhexiline maleate [6724-53-4]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 1.51e-03 | 170 | 8 | 2 | 5501_UP | |
| Drug | pyrvinium pamoate; Up 200; 1.25uM; MCF7; HT_HG-U133A_EA | 1.51e-03 | 170 | 8 | 2 | 978_UP | |
| Drug | rottlerin; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 1.51e-03 | 170 | 8 | 2 | 941_UP | |
| Drug | felodipine; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 1.51e-03 | 170 | 8 | 2 | 965_UP | |
| Drug | Digoxigenin [1672-46-4]; Up 200; 10.2uM; PC3; HT_HG-U133A | 1.51e-03 | 170 | 8 | 2 | 4680_UP | |
| Drug | Cephaeline dihydrochloride heptahydrate [6487-30-5]; Up 200; 6uM; MCF7; HT_HG-U133A | 1.52e-03 | 171 | 8 | 2 | 5247_UP | |
| Drug | Cephaeline dihydrochloride heptahydrate [6487-30-5]; Up 200; 6uM; MCF7; HT_HG-U133A | 1.56e-03 | 173 | 8 | 2 | 5612_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.56e-03 | 173 | 8 | 2 | 2881_DN | |
| Drug | Strophantine octahydrate [11018-89-6]; Up 200; 5.4uM; HL60; HT_HG-U133A | 1.58e-03 | 174 | 8 | 2 | 1302_UP | |
| Drug | Ciclopirox ethanolamine [41621-49-2]; Up 200; 15uM; HL60; HT_HG-U133A | 1.58e-03 | 174 | 8 | 2 | 2456_UP | |
| Drug | Chlorprothixene hydrochloride [6469-93-8]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 1.61e-03 | 176 | 8 | 2 | 5291_UP | |
| Drug | Emetine dihydrochloride [316-42-7]; Up 200; 7.2uM; MCF7; HT_HG-U133A | 1.61e-03 | 176 | 8 | 2 | 4827_UP | |
| Drug | pararosaniline base; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 1.63e-03 | 177 | 8 | 2 | 893_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.65e-03 | 178 | 8 | 2 | 4710_DN | |
| Drug | Budesonide [51333-22-3]; Up 200; 9.2uM; HL60; HG-U133A | 1.65e-03 | 178 | 8 | 2 | 1716_UP | |
| Drug | thioridazine hydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A | 1.67e-03 | 179 | 8 | 2 | 5590_UP | |
| Drug | Chlorpromazine hydrochloride [69-09-0]; Up 200; 11.2uM; PC3; HT_HG-U133A | 1.67e-03 | 179 | 8 | 2 | 5074_UP | |
| Drug | thioridazine hydrochloride; Up 200; 10uM; HL60; HT_HG-U133A | 1.69e-03 | 180 | 8 | 2 | 1171_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.69e-03 | 180 | 8 | 2 | 6454_DN | |
| Drug | GBR 12909 dihydrochloride [67469-78-7]; Up 200; 7.6uM; PC3; HT_HG-U133A | 1.69e-03 | 180 | 8 | 2 | 4641_UP | |
| Drug | Primaquine diphosphate [63-45-6]; Up 200; 8.8uM; HL60; HT_HG-U133A | 1.74e-03 | 183 | 8 | 2 | 1343_UP | |
| Drug | valinomycin; Up 200; 0.1uM; PC3; HT_HG-U133A | 1.76e-03 | 184 | 8 | 2 | 5911_UP | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.76e-03 | 184 | 8 | 2 | 1064_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A | 1.76e-03 | 184 | 8 | 2 | 1835_DN | |
| Drug | Perphenazine [58-39-9]; Up 200; 10uM; MCF7; HT_HG-U133A | 1.76e-03 | 184 | 8 | 2 | 1540_UP | |
| Drug | (1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.78e-03 | 185 | 8 | 2 | 3893_UP | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 1.78e-03 | 185 | 8 | 2 | 831_UP | |
| Drug | clotrimazole; Up 200; 50uM; MCF7; HT_HG-U133A_EA | 1.78e-03 | 185 | 8 | 2 | 905_UP | |
| Drug | Rolitetracycline [751-97-3]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 1.78e-03 | 185 | 8 | 2 | 3369_DN | |
| Drug | Apigenin [520-36-5]; Down 200; 14.8uM; PC3; HT_HG-U133A | 1.80e-03 | 186 | 8 | 2 | 4578_DN | |
| Drug | Pyrvinium pamoate [3546-41-6]; Down 200; 3.4uM; MCF7; HT_HG-U133A | 1.80e-03 | 186 | 8 | 2 | 3518_DN | |
| Drug | Metixene hydrochloride [1553-34-0]; Up 200; 11.6uM; PC3; HT_HG-U133A | 1.80e-03 | 186 | 8 | 2 | 6672_UP | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.80e-03 | 186 | 8 | 2 | 831_DN | |
| Drug | Rescinnamin [24815-24-5]; Up 200; 6.4uM; HL60; HT_HG-U133A | 1.80e-03 | 186 | 8 | 2 | 2130_UP | |
| Drug | Methyl benzethonium chloride [25155-18-4]; Up 200; 8.6uM; PC3; HT_HG-U133A | 1.80e-03 | 186 | 8 | 2 | 3768_UP | |
| Drug | 0297417-0002B [362658-29-5]; Up 200; 10uM; MCF7; HT_HG-U133A | 1.82e-03 | 187 | 8 | 2 | 6902_UP | |
| Drug | Betulinic acid [472-15-1]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 1.84e-03 | 188 | 8 | 2 | 3281_UP | |
| Drug | Nifuroxazide [965-52-6]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 1.84e-03 | 188 | 8 | 2 | 4835_DN | |
| Drug | Alexidine dihydrochloride [22573-93-9]; Up 200; 6.8uM; PC3; HT_HG-U133A | 1.84e-03 | 188 | 8 | 2 | 7397_UP | |
| Drug | Ketanserin tartrate hydrate [83846-83-7]; Down 200; 7uM; PC3; HT_HG-U133A | 1.86e-03 | 189 | 8 | 2 | 6649_DN | |
| Drug | Benzbromarone [3562-84-3]; Up 200; 9.4uM; HL60; HT_HG-U133A | 1.86e-03 | 189 | 8 | 2 | 1291_UP | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 1.86e-03 | 189 | 8 | 2 | 1651_DN | |
| Drug | Benzethonium chloride [121-54-0]; Down 200; 9uM; HL60; HT_HG-U133A | 1.86e-03 | 189 | 8 | 2 | 2508_DN | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 1.86e-03 | 189 | 8 | 2 | 5203_DN | |
| Drug | Resveratrol [501-36-0]; Down 200; 17.6uM; PC3; HT_HG-U133A | 1.86e-03 | 189 | 8 | 2 | 5084_DN | |
| Drug | Isoflupredone acetate [338-98-7]; Down 200; 9.6uM; PC3; HT_HG-U133A | 1.86e-03 | 189 | 8 | 2 | 1832_DN | |
| Drug | Perphenazine [58-39-9]; Up 200; 10uM; PC3; HT_HG-U133A | 1.88e-03 | 190 | 8 | 2 | 4637_UP | |
| Drug | F0447-0125; Up 200; 10uM; PC3; HT_HG-U133A | 1.88e-03 | 190 | 8 | 2 | 6429_UP | |
| Drug | Econazole nitrate [24169-02-6]; Down 200; 9uM; PC3; HT_HG-U133A | 1.88e-03 | 190 | 8 | 2 | 7305_DN | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.88e-03 | 190 | 8 | 2 | 1056_DN | |
| Drug | Clioquinol [130-26-7]; Up 200; 13uM; PC3; HT_HG-U133A | 1.88e-03 | 190 | 8 | 2 | 4663_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; HL60; HT_HG-U133A | 1.88e-03 | 190 | 8 | 2 | 1150_DN | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.88e-03 | 190 | 8 | 2 | 1044_DN | |
| Drug | thapsigargin; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.90e-03 | 191 | 8 | 2 | 7100_DN | |
| Drug | Methotrexate [59-05-2]; Up 200; 8.8uM; HL60; HG-U133A | 1.90e-03 | 191 | 8 | 2 | 2041_UP | |
| Drug | Desipramine hydrochloride [58-28-6]; Up 200; 13.2uM; PC3; HT_HG-U133A | 1.90e-03 | 191 | 8 | 2 | 6693_UP | |
| Drug | Nifuroxazide [965-52-6]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 1.90e-03 | 191 | 8 | 2 | 2850_DN | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.90e-03 | 191 | 8 | 2 | 998_DN | |
| Drug | Trifluoperazine dihydrochloride [440-17-5]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 1.90e-03 | 191 | 8 | 2 | 5442_DN | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 1.90e-03 | 191 | 8 | 2 | 6944_DN |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PLVAPPKPPPLPPWK | 466 | Q8N7X0 | |
| PKPPPLPPWKLIRQK | 471 | Q8N7X0 | |
| SPWKPPPKPLMPPLR | 551 | Q6UY09 | |
| PPPPPPAVLAKPKLW | 321 | P78411 | |
| LLRPPPPPAWLKGPA | 476 | O15054 | |
| WCKMPPPPPKPRYAP | 626 | P35663 | |
| KLPVDKILPPPSPWP | 166 | Q9UJY4 | |
| EKPPPPWAPPRLPLR | 516 | O75807 | |
| KAPKEEKRPPWAPPP | 186 | Q8TBZ2 |